Clinical Trials Browser

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.

A Study of TY-1091 in Patients With Advanced Solid Tumors

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma

A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors

A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma

APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

A Study of TQB3454 Tablets in Patients With Blood Tumors

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma

A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer

IMX-110 in Patients With Advanced Solid Tumors

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer

SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation

HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors

HLX301

IMMINENT-01